Format

Send to

Choose Destination
Front Immunol. 2014 Mar 3;5:83. doi: 10.3389/fimmu.2014.00083. eCollection 2014.

TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects.

Author information

1
Tumor Vaccine Group, University of Washington , Seattle, WA , USA.

KEYWORDS:

IL-10; PD-L1; TLR; Treg; cancer immunotherapy

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center